Medical Science News RSS Feed - Medical Science News

Females' natural resistance to bacterial pneumonia is linked to NOS3 enzyme

Females' natural resistance to bacterial pneumonia is linked to NOS3 enzyme

Researchers have linked increased resistance to bacterial pneumonia in female mice to an enzyme activated by the female sex hormone estrogen. [More]
Newly developed agent filters out toxins from body in the event of overdose

Newly developed agent filters out toxins from body in the event of overdose

Every minute counts in the event of an overdose. ETH professor Jean-Christophe Leroux and his team have developed an agent to filter out toxins from the body more quickly and efficiently. [More]
New automaton model simulates various scenarios of tumor growth

New automaton model simulates various scenarios of tumor growth

Cancer constantly wages war on the human body. Battles are won, lost or sometimes end in a stalemate. In pancreatic cancer, this stalemate—known as tumor dormancy—can last up to 25 years before becoming aggressively malignant, a phenomena that is poorly understood. [More]
Genetic risk for ADHD contributes to language, attention deficits in general population

Genetic risk for ADHD contributes to language, attention deficits in general population

Are deficits in attention limited to those with attention-deficit/hyperactivity disorder (ADHD) or is there a spectrum of attention function in the general population? [More]
Scientists map DNA replication process at the most fundamental level

Scientists map DNA replication process at the most fundamental level

The proteins that drive DNA replication—the force behind cellular growth and reproduction—are some of the most complex machines on Earth. [More]
IU Bloomington biologists to receive funding from NSF’s Dimensions of Biodiversity Program

IU Bloomington biologists to receive funding from NSF’s Dimensions of Biodiversity Program

Indiana University Bloomington biologists who specialize in the ecology and evolution of microbes have been named one of 12 teams in the nation to receive funding from the National Science Foundation's Dimensions of Biodiversity Program. [More]
Nanotechnology expert from PETA Science Consortium to outline hazard testing strategy at ECHA workshop

Nanotechnology expert from PETA Science Consortium to outline hazard testing strategy at ECHA workshop

The PETA International Science Consortium's nanotechnology expert will present a poster titled "A Tiered-Testing Strategy for Nanomaterial Hazard Assessment" at the Topical Scientific Workshop – Regulatory Challenges in Risk Assessment of Nanomaterials being organized by the European Chemicals Agency (ECHA) on October 23 and 24 in Helsinki. [More]
Melbourne researchers suggest new mechanism for bowel cancer development

Melbourne researchers suggest new mechanism for bowel cancer development

Melbourne researchers have challenged conventional thinking on how the bowel lining develops and, in the process, suggested a new mechanism for how bowel cancer starts. [More]
Scientists identify two microRNA molecules that control chronic inflammation

Scientists identify two microRNA molecules that control chronic inflammation

University of Utah scientists have identified two microRNA molecules that control chronic inflammation, a discovery that one day may help researchers prevent certain fatal or debilitating conditions before they start. [More]
Mexican students create zero calorie sweetener for people with diabetes, hypertension, obesity

Mexican students create zero calorie sweetener for people with diabetes, hypertension, obesity

Since Elsa Martinez was diagnosed with type II diabetes she made sure to be informed about those food products that wouldn't aggravate her health. [More]
Researchers identify novel method to develop personalized vaccines for ovarian cancer

Researchers identify novel method to develop personalized vaccines for ovarian cancer

Researchers at the University of Connecticut have found a new way to identify protein mutations in cancer cells. The novel method is being used to develop personalized vaccines to treat patients with ovarian cancer. [More]
Intellimedix brings new approach to solve Ebola outbreak

Intellimedix brings new approach to solve Ebola outbreak

Amidst the Ebola outbreak and subsequent research efforts, Atlanta-based Intellimedix is bringing a new approach to the table. Classical methods of drug development involve performing many experiments only to identify new molecules with a few desired effects. [More]
New study to explore how NHS re-contacts patients with genetic information

New study to explore how NHS re-contacts patients with genetic information

A new study will be examining the implications of when and how NHS healthcare professionals re-contact patients with new genetic information that may impact their health or that of their family. The three year Economic and Social Research Council funded research will also explore issues of consent and how genetic information is stored. [More]
Discovery offers insight on early stages of cancer

Discovery offers insight on early stages of cancer

The discovery of a cellular snooze button has allowed a team of Michigan State University scientists to potentially improve biofuel production and offer insight on the early stages of cancer. [More]
New oral biologic medication successfully treats precancerous intestinal inflammation

New oral biologic medication successfully treats precancerous intestinal inflammation

An oral biologic medication has successfully treated chronic, precancerous inflammation in the intestine, according to results of an animal study authored by an MD/PhD student in the University at Buffalo School of Medicine and Biomedical Sciences. [More]
Cell transplantation treatment may benefit people with spinal cord injury

Cell transplantation treatment may benefit people with spinal cord injury

Two studies recently published in Cell Transplantation reveal that cell transplantation may be an effective treatment for spinal cord injury (SCI), a major cause of disability and paralysis with no current restorative therapies. [More]
Researchers identify two microRNA molecules that control chronic inflammation

Researchers identify two microRNA molecules that control chronic inflammation

University of Utah scientists have identified two microRNA molecules that control chronic inflammation, a discovery that one day may help researchers prevent certain fatal or debilitating conditions before they start. [More]
NIH presents 2014 New Innovator Award to Penn Medicine researcher

NIH presents 2014 New Innovator Award to Penn Medicine researcher

Roberto Bonasio, PhD, an assistant professor of Cell and Developmental Biology, Perelman School of Medicine at the University of Pennsylvania, and a core member of the Penn Epigenetics Program is one of the recipients of a 2014 New Innovator Award from the National Institutes of Health (NIH). [More]
New mutations in cat genome identified as causes of human eye diseases

New mutations in cat genome identified as causes of human eye diseases

Researchers from the University of Missouri and the 99 Lives Cat Genome Sequencing Initiative today announced groundbreaking discoveries of novel mutations in the cat genome found to correlate to two human eye diseases, retinitis pigmentosa and Leber's Congenital Amaurosis. [More]

Study: Tbx5 protein contributes to formation of epicardium, pericardium, coronary vessels

Congenital heart defects are the most common birth defect, affecting 8 out of every 1,000 newborns according to the National Heart, Lung and Blood Institute. In the U.S., more than 35,000 babies are born annually with some sort of heart defect. [More]